Update on Cytomegalovirus Infection Management in Allogeneic Hematopoietic Stem Cell Transplant Recipients. A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)

[Background]: Cytomegalovirus (CMV) infection is a common complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT) and in patients receiving novel hematological therapies. Its impact on morbidity and mortality necessitates effective management strategies. Despite recent...

Descripción completa

Detalles Bibliográficos
Autores: Piñana, José Luis, Giménez, Estela, Vázquez, Lourdes, Marcos, María Ángeles, Guerreiro, Manuel, Duarte, Rafael F., Pérez, Ariadna, Miguel, Carlos de, Espigado, Ildefonso, González-Vicent, Marta, Suarez-Lledó, María, García-Cadenas, Irene, Martino, Rodrigo, Cedillo, Ángel, Rovira, Montserrat, Cámara, Rafael de la, Navarro, David, Solano, Carlos
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2024
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/382200
Acceso en línea:http://hdl.handle.net/10261/382200
Access Level:acceso abierto
Palabra clave:Cytomegalovirus
CMV monitoring
Antiviral prophylaxis
Preemptive antiviral therapy
CMV DNA doubling time
CMV-specific T-cell immunity
Clinically significant CMV infection
Descripción
Sumario:[Background]: Cytomegalovirus (CMV) infection is a common complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT) and in patients receiving novel hematological therapies. Its impact on morbidity and mortality necessitates effective management strategies. Despite recent advances in diagnostics and treatment, unresolved questions persist regarding monitoring and treatment, prompting the need for updated recommendations.

Similares en LA Referencia